Cargando…
Nanoparticle-Based Combination Therapy for Melanoma
Melanoma is a cutaneous carcinoma, and its incidence is rapidly increasing with every year. The treatment options for melanoma have been comprehensively studied. Conventional treatment methods (e.g., radiotherapy, chemotherapy and photodynamic therapy) with surgical removal inevitably cause serious...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273962/ https://www.ncbi.nlm.nih.gov/pubmed/35837089 http://dx.doi.org/10.3389/fonc.2022.928797 |
_version_ | 1784745210351190016 |
---|---|
author | Chen, Hongbo Hou, Kai Yu, Jing Wang, Le Chen, Xue |
author_facet | Chen, Hongbo Hou, Kai Yu, Jing Wang, Le Chen, Xue |
author_sort | Chen, Hongbo |
collection | PubMed |
description | Melanoma is a cutaneous carcinoma, and its incidence is rapidly increasing with every year. The treatment options for melanoma have been comprehensively studied. Conventional treatment methods (e.g., radiotherapy, chemotherapy and photodynamic therapy) with surgical removal inevitably cause serious complications; moreover, resistance is common. Nanoparticles (NPs) combined with conventional methods are new and promising options to treat melanoma, and many combinations have been achieving good success. Due to their physical and biological features, NPs can help target intended melanoma cells more efficiently with less damage. This creates new hope for a better treatment strategy for melanoma with minimum damage and maximum efficacy. |
format | Online Article Text |
id | pubmed-9273962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92739622022-07-13 Nanoparticle-Based Combination Therapy for Melanoma Chen, Hongbo Hou, Kai Yu, Jing Wang, Le Chen, Xue Front Oncol Oncology Melanoma is a cutaneous carcinoma, and its incidence is rapidly increasing with every year. The treatment options for melanoma have been comprehensively studied. Conventional treatment methods (e.g., radiotherapy, chemotherapy and photodynamic therapy) with surgical removal inevitably cause serious complications; moreover, resistance is common. Nanoparticles (NPs) combined with conventional methods are new and promising options to treat melanoma, and many combinations have been achieving good success. Due to their physical and biological features, NPs can help target intended melanoma cells more efficiently with less damage. This creates new hope for a better treatment strategy for melanoma with minimum damage and maximum efficacy. Frontiers Media S.A. 2022-06-28 /pmc/articles/PMC9273962/ /pubmed/35837089 http://dx.doi.org/10.3389/fonc.2022.928797 Text en Copyright © 2022 Chen, Hou, Yu, Wang and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Chen, Hongbo Hou, Kai Yu, Jing Wang, Le Chen, Xue Nanoparticle-Based Combination Therapy for Melanoma |
title | Nanoparticle-Based Combination Therapy for Melanoma |
title_full | Nanoparticle-Based Combination Therapy for Melanoma |
title_fullStr | Nanoparticle-Based Combination Therapy for Melanoma |
title_full_unstemmed | Nanoparticle-Based Combination Therapy for Melanoma |
title_short | Nanoparticle-Based Combination Therapy for Melanoma |
title_sort | nanoparticle-based combination therapy for melanoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273962/ https://www.ncbi.nlm.nih.gov/pubmed/35837089 http://dx.doi.org/10.3389/fonc.2022.928797 |
work_keys_str_mv | AT chenhongbo nanoparticlebasedcombinationtherapyformelanoma AT houkai nanoparticlebasedcombinationtherapyformelanoma AT yujing nanoparticlebasedcombinationtherapyformelanoma AT wangle nanoparticlebasedcombinationtherapyformelanoma AT chenxue nanoparticlebasedcombinationtherapyformelanoma |